Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.470
-0.030 (-1.20%)
At close: Feb 27, 2026, 4:00 PM EST
2.454
-0.016 (-0.66%)
After-hours: Feb 27, 2026, 7:49 PM EST

BDTX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
141121145651931,154
Market Cap Growth
10.05%-16.54%121.66%-66.10%-83.26%-
Enterprise Value
253127-50-13829
Last Close Price
2.472.142.811.805.3332.05
PB Ratio
1.111.451.240.570.993.75
P/TBV Ratio
1.121.451.240.570.993.75
Debt / Equity Ratio
0.160.270.220.240.140.03
Net Debt / Equity Ratio
-0.92-0.92-0.91-0.82-0.93-0.99
Net Debt / EBITDA Ratio
-7.651.011.231.021.434.41
Net Debt / FCF Ratio
-5.431.231.591.111.765.86
Quick Ratio
8.724.796.698.058.8722.16
Current Ratio
8.944.926.828.379.1222.48
Return on Equity (ROE)
19.23%-69.67%-70.94%-58.52%-49.87%-29.17%
Return on Assets (ROA)
6.26%-33.71%-34.33%-28.73%-27.47%-17.82%
Return on Capital Employed (ROCE)
10.40%-74.30%-62.20%-65.80%-56.60%-22.10%
Earnings Yield
15.28%-57.54%-56.82%-139.28%-65.04%-5.83%
FCF Yield
15.17%-51.45%-46.00%-130.27%-53.27%-4.53%
Buyback Yield / Dilution
-6.44%-25.19%-21.00%-0.38%-9.97%-1485.31%
Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q